Generic Name and Formulations:
Epinastine HCl 0.05%; oph soln; contains benzalkonium chloride.
Indications for ELESTAT:
Prevention of itching due to allergic conjunctivitis.
Adults and Children:
<2yrs: not established. ≥2yrs: 1 drop in each eye twice daily.
Remove contact lenses; may reinsert 10 minutes after dosing if eye is not red. Pregnancy (Cat.C). Nursing mothers.
Ocular effects (eg, burning sensation, folliculosis, hyperemia, pruritus), cold symptoms, upper respiratory infections, headache, rhinitis, sinusitis, increased cough, pharyngitis.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Unintended Pregnancy Common in Women With Epilepsy
- Aggressive Blood Pressure Lowering in Intracerebral Hemorrhage May Be Harmful
- Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing
- Minority Residents Experience Burdens Linked to Race/Ethnicity
- Tips Provided for Budgeting in Medical Residency